Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Circulating memory-effector T-cells useful marker for predicting alefacept responders
In patients with chronic plaque psoriasis treatedwith the human LFA-3/IgG1 fusion protein alefacept (Amevive), early reductionin circulating memory-effector CD45RO+ T-cells may be used to predict ultimateclinical improvement,
Related Videos
Related Content
